Effect of fenfluramine on non-insulin dependent diabetes with sulfonylurea drug failure

Xin Gao,Saijuan Chen,Yehong Yang

1995-01-01

Abstract:31 subjects with non-insulin dependent diabetes (NIDDM) after sulfonylurea (SU) drug failure were treated with the maximum dose SU drug plus fenfluramine. The initial dose of fenfluramine was 20 mg/day during the first week, and 40 mg/day from the second week on till the end of six weeks. During the study, all patients persisted in a diabetic diet and no absorption disorders were present. Before and after fenfluramine administration (10 days later), 10 patients underwent insulin-sensitivity test. The results showed that FBG, PBG, HbA1C dropped, (FBG from 12.05 �� 2.38 mmol/L to 8.35 �� 3.43 mmol/L, P < 0.001; PBG from 19.06 �� 5.45 mmol/L to 13.18 �� 5.37 mmol/L, P < 0.001; HbA1C from 9.51 �� 2.42% to 6.68 �� 1.31%, P < 0.001), but the insulin level either the early-phase or later-phase and BMI remained unchanged. The insulin-sensitivity test suggested that the plasma glucose level at each point was lower than before fenfluramine administration. We conclude that the hypoglycemic effect of fenfluramine is effective not only in newly diagnosed NIDDM but also in those with secondary sulfonylurea drug failure. Using maximum doses SU drug combined with fenfluramine is a valuable method for the management of NIDDM patients with secondary SU drug failure.